Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023
DOI: 10.1016/j.bbcan.2023.188888 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023. Verfasst von Vipul Bhardwaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, PR China; Institute of B…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Genital Neoplasms, Male. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 338 Literaturangaben.
Abstract (Originalsprache)
The process of angiogenesis is well described for its potential role in the development of normal ovaries, and physiological functions as well as in the initiation, progression, and metastasis of ovarian cancer (OC). In advanced stages of OC, cancer cells spread outside the ovary to the pelvic, abdomen, lung, or multiple secondary sites. This seriously limits the efficacy of therapeutic options contributing to fatal clinical outcomes. Notably, a variety of angiogenic effectors are produced by the tumor cells to initiate angiogenic processes leading to the development of new blood vessels, which provide essential resources for tumor survival, dissemination, and dormant micro-metastasis of tumor cells. Multiple proangiogenic effectors and their signaling axis have been discovered and functionally characterized for potential clinical utility in OC. In this review, we have provided the current updates on classical and emerging proangiogenic effectors, their signaling axis, and the immune microenvironment contributing to the pathogenesis of OC. Moreover, we have comprehensively reviewed and discussed the significance of the preclinical strategies, drug repurposing, and clinical trials targeting the angiogenic processes that hold promising perspectives for the better management of patients with OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, PR China; Institute of Biopharmaceutical and Bioengineering, Tsinghua Shenzhen International G…
- Shenzhen Bay Laboratory, Shenzhen 518055, PR China.
- Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Uttar Pradesh, Sector-125, Noida 201301, India. Electronic address: mgarg@amity.edu.
Zitieren
APA
Bhardwaj, V., Zhang, X., Pandey, V., & Garg, M. (2023). Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2023.188888
Vancouver
Bhardwaj V, Zhang X, Pandey V, Garg M. Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023. doi:10.1016/j.bbcan.2023.188888
BibTeX
@article{Bhardwaj2023,
author = {Bhardwaj, Vipul and Zhang, Xi and Pandey, Vijay and Garg, Manoj},
title = {Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
doi = {10.1016/j.bbcan.2023.188888}
}
EUVIMED